Innate Pharma (France)

Innate Pharma (France)

Open Access statistics for Innate Pharma (France), France, covering academic research published from 2000 to 2023.

Open Access statistics for Innate Pharma (France), France, covering academic research published from 2000 to 2023. Read More.


Open Access Percentage

61%


Total
Publications

461


Total Open
Publications

283


Total
Citations

24K


Open Access
Percentage

61%


Total
Publications

461


Total Open
Publications

283


Total
Citations

24K

Website

download

Breakdown

19% 32% 10% 39%

Publisher Open

19%

Both

32%

Other Platform Open

10%

Closed

39%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

051015202530354045Total Publications
200020012002200320042005200620072008200920102011201220132014201520162017201820192020202120222023

Open

Closed

Publisher Open

30%OA Journal

OA Journal 30%

72

Hybrid 28%

66

No Guarantees 42%

100

Other Platform Open

Domain 80%

156

Institution 46%

90

Other Internet 17%

33

Public 9%

18

Preprint 7%

14

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
153
Europe PMC
Domain
103
Le Centre pour la Communication Scientifique Directe - HAL - Université de Nantes
Institution
29
Le Centre pour la Communication Scientifique Directe - HAL - Aix-Marseille Université
Institution
29
Le Centre pour la Communication Scientifique Directe - HAL - memSIC
Other Internet
28
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
22
Le Centre pour la Communication Scientifique Directe - HAL - Université Paris Descartes
Institution
18
Le Centre pour la Communication Scientifique Directe - HAL - Inria
Institution
18
Le Centre pour la Communication Scientifique Directe - HAL - Inserm
Institution
12
Semantic Scholar
Public
11
1 / 8

Data updated 17 June 2024

Share

Share

Share